(MENAFN) The Danish Health Authority has made a decision to suspend the use of the Johnson & Johnson vaccine in its mass COVID-19 inoculation drive.
The Danish Health Authority's Deputy Director General Helene Probst stated in a press publication: "taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from COVID-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate."
"In the midst of an epidemic, this has been a difficult decision to make, especially since we have also had to discontinue using the COVID-19 vaccine from AstraZeneca."
The authority's conclusion that "the benefits do not outweigh the risks" comes after the European Medicines Agency (EMA) assumed that there was a possible connection between unusual but serious cases of blood clots (vaccine-induced immune thrombotic thrombocytopenia or VITT) and the coronavirus vaccine from Johnson & Johnson.
MENAFN04052021000045011361ID1102023451
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.